Tumor microenvironment and ubiquitin system in platinum resistance urothelial carcinoma

铂类耐药尿路上皮癌的肿瘤微环境和泛素系统

• 批准号: 26462429
• 负责人: TANAKA NOBUYUKI
• 金额: $ 3.24万
• 依托单位: Keio University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (C)
• 财政年份: 2014
• 资助国家: 日本
• 起止时间: 2014-04-01 至 2017-03-31
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26462429/
• 关键词: 尿路上皮癌; 上皮間葉転換; シスプラチン; FBXO32; 抗がん剤耐性; ユビキチン

项目成果

Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer.

• DOI: 10.1186/s12885-015-1315-9
• 发表时间: 2015-04-29
• 期刊: BMC cancer
• 影响因子: 3.8
• 作者: Ito Y;Kikuchi E;Tanaka N;Kosaka T;Suzuki E;Mizuno R;Shinojima T;Miyajima A;Umezawa K;Oya M
• 通讯作者: Oya M

Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers: A matched-pair analysis

超声检查和膀胱镜检查在初诊 TaG1-2 膀胱癌患者监测中的结果比较：配对分析

• DOI: 10.1016/j.urolonc.2015.04.018
• 发表时间: 2015
• 期刊: Urologic Oncology: Seminars and Original Investigations
• 作者: Naoya Niwa;Kazuhiro Matsumoto;Nozomi Hayakawa;Yujiro Ito;Takahiro Maeda;Seiya Akatsuka;Takeshi Masuda;So Nakamura;Nobuyuki Tanaka
• 通讯作者: Nobuyuki Tanaka

Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings

IMDC模型重新分类对一线和二线靶向治疗转移性肾细胞癌患者的影响

• DOI: 10.1016/j.urolonc.2016.02.023
• 发表时间: 2016
• 期刊: Urol Oncol
• 作者: Tanaka N;Mizuno R;Shirotake S;Ito K;Yasumizu Y;Masunaga A;Ito Y;Miyazaki Y;Hagiwara M;Kanao K;Mikami S;Nakagawa K;Momma T;Masuda T;Asano T;Oyama M;Oya M
• 通讯作者: Oya M

慶應義塾大学医学部 泌尿器科学教室

庆应义塾大学医学院泌尿外科

Impact of Second-Line Targeted Therapy Dose Intensity on Patients With Metastatic Renal Cell Carcinoma

• DOI: 10.1016/j.clgc.2016.03.014
• 发表时间: 2016-12-01
• 期刊: CLINICAL GENITOURINARY CANCER
• 影响因子: 3.2
• 作者: Shirotake, Suguru;Yasumizu, Yota;Oya, Mototsugu
• 通讯作者: Oya, Mototsugu